Steve Martin
2021 - AmpliPhi Biosciences
In 2021, Steve Martin earned a total compensation of $739K as Chief Financial Officer at AmpliPhi Biosciences, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,320 |
|---|---|
| Option Awards | $219,898 |
| Salary | $370,800 |
| Total | $739,018 |
Martin received $370.8K in salary, accounting for 50% of the total pay in 2021.
Martin also received $148.3K in non-equity incentive plan and $219.9K in option awards.
Rankings
In 2021, Steve Martin's compensation ranked 9,717th out of 12,397 executives tracked by ExecPay. In other words, Martin earned more than 21.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,717 out of 12,397 | 22nd |
Division Manufacturing | 4,301 out of 5,492 | 22nd |
Major group Chemicals And Allied Products | 1,905 out of 2,367 | 20th |
Industry group Drugs | 1,692 out of 2,090 | 19th |
Industry Biological Products, Except Diagnostic Substances | 372 out of 452 | 18th |
Source: SEC filing on October 17, 2022.
Martin's colleagues
We found two more compensation records of executives who worked with Steve Martin at AmpliPhi Biosciences in 2021.